Literature DB >> 33763070

Interplay Between Sialic Acids, Siglec-E, and Neu1 Regulates MyD88- and TRIF-Dependent Pathways for TLR4-Activation During Leishmania donovani Infection.

Joyshree Karmakar1, Chitra Mandal1.   

Abstract

TLR4 activates two distinct signaling pathways involving adaptors MyD88 and TRIF to produce proinflammatory cytokines and type-I interferon respectively. How Leishmania donovani suppresses these pathways is not well studied. We earlier reported, TLR4 is hypersialylated due to reduced membrane-bound neuraminidase (Neu1) on infected-macrophages. We hypothesized that such enhanced sialoglycoconjugates on host cells may modulate the interactions with siglecs- which are the inhibitory receptors. Here, we examined the impact of such sialylation on overall TLR4 activation both in murine cell line J774A.1 and primary bone marrow derived macrophages (BMDM). Supporting this hypothesis, we demonstrated siglec-E engages hypersialylated TLR4 during infection. Such sialic acids-siglec-E interaction enhanced siglec-E phosphorylation that mediated its strong association with SHP1/SHP2 and also upregulated their phosphorylation in both types of macrophages. Pre-treatment of parasites and host cells with neuraminidase reduced SHP1/SHP2 phosphorylation and triggered TLR4 activation respectively through enhanced nuclear translocation of p-65. Moreover, a reciprocal interplay between Neu1 and siglec-E differentially regulates MyD88- and TRIF-pathways through sialic acids on TLR4 as their common substrate during infection. Correspondingly, Neu1 overexpression enhanced MyD88-signaling while still suppressing TRIF-activation. However, silencing siglec-E specifically activated TRIF-signaling. Pro-inflammatory cytokines corresponding to MyD88 and TRIF pathways were also upregulated respectively. Additionally, Neu1 overexpression or siglec-E silencing prevented TLR4 ubiquitination and subsequent degradation by Triad3A. Neu1-overexpression and siglec-E-silencing together followed by infection activated both MyD88 and TRIF-signaling through their enhanced TLR4-association. This elevated the MyD88-specific cytokines and TRIF-mediated IRF3 and IFN-β genes, thus upregulating the pro-inflammatory cytokines and nitric oxide levels and reduced anti-inflammatory cytokines. All these significantly inhibited parasite survival in macrophages thus demonstrating a previously unidentified dualistic regulation of TLR4signaling pathways activation through sialic acids by interplay of Neu1 and siglec-E during Leishmania infection.
Copyright © 2021 Karmakar and Mandal.

Entities:  

Keywords:  MyD88; Neu1; TLR4; TRIF; cytokines; sialic acids; siglec-E

Year:  2021        PMID: 33763070      PMCID: PMC7982817          DOI: 10.3389/fimmu.2021.626110

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  52 in total

Review 1.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

Review 2.  Toll-like receptors in innate immunity.

Authors:  Kiyoshi Takeda; Shizuo Akira
Journal:  Int Immunol       Date:  2005-01       Impact factor: 4.823

3.  Toll-like receptor signaling pathways.

Authors:  Gregory M Barton; Ruslan Medzhitov
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

4.  Identification and characterization of adsorbed serum sialoglycans on Leishmania donovani promastigotes.

Authors:  Mitali Chatterjee; Anil Kumar Chava; Guido Kohla; Santanu Pal; Anette Merling; Stephan Hinderlich; Ulrike Unger; Peter Strasser; Gerrit J Gerwig; Johannis P Kamerling; Reinhard Vlasak; Paul R Crocker; Roland Schauer; Reinhard Schwartz-Albiez; Chitra Mandal
Journal:  Glycobiology       Date:  2002-12-17       Impact factor: 4.313

5.  TGF-β1 re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20.

Authors:  Sushmita Das; Krishna Pandey; Ashish Kumar; Abul H Sardar; Bidyut Purkait; Manish Kumar; Sudeep Kumar; Vidya N Ravidas; Syamal Roy; Dharmendra Singh; Pradeep Das
Journal:  Immunol Cell Biol       Date:  2011-10-04       Impact factor: 5.126

6.  Leishmania EF-1alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation.

Authors:  Devki Nandan; Taolin Yi; Martin Lopez; Crystal Lai; Neil E Reiner
Journal:  J Biol Chem       Date:  2002-10-15       Impact factor: 5.157

7.  Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production.

Authors:  Caroline R Boyd; Selinda J Orr; Shaun Spence; James F Burrows; Joanne Elliott; Helen P Carroll; Kiva Brennan; Joan Ní Gabhann; Wilson A Coulter; Claire Jones; Paul R Crocker; James A Johnston; Caroline A Jefferies
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  Siglec-E Negatively Regulates the Activation of TLR4 by Controlling Its Endocytosis.

Authors:  Yin Wu; Dongren Ren; Guo-Yun Chen
Journal:  J Immunol       Date:  2016-09-12       Impact factor: 5.422

9.  Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase.

Authors:  Schammim Ray Amith; Preethi Jayanth; Susan Franchuk; Sarah Siddiqui; Volkan Seyrantepe; Katrina Gee; Sameh Basta; Rudi Beyaert; Alexey V Pshezhetsky; Myron R Szewczuk
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

10.  Sialic acids acquired by Pseudomonas aeruginosa are involved in reduced complement deposition and siglec mediated host-cell recognition.

Authors:  Biswajit Khatua; Angana Ghoshal; Kaushik Bhattacharya; Chandan Mandal; Bibhuti Saha; Paul R Crocker; Chitra Mandal
Journal:  FEBS Lett       Date:  2009-11-27       Impact factor: 4.124

View more
  4 in total

1.  Serum Linkage-Specific Sialylation Changes Are Potential Biomarkers for Monitoring and Predicting the Recurrence of Papillary Thyroid Cancer Following Thyroidectomy.

Authors:  Zhen Cao; Zejian Zhang; Rui Liu; Mengwei Wu; Zepeng Li; Xiequn Xu; Ziwen Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-29       Impact factor: 6.055

2.  Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond.

Authors:  Erik P Lillehoj; Irina G Luzina; Sergei P Atamas
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

3.  Ablation of Siglec-E augments brain inflammation and ischemic injury.

Authors:  Lexiao Li; Yu Chen; Madison N Sluter; Ruida Hou; Jiukuan Hao; Yin Wu; Guo-Yun Chen; Ying Yu; Jianxiong Jiang
Journal:  J Neuroinflammation       Date:  2022-07-20       Impact factor: 9.587

Review 4.  Neuraminidases-Key Players in the Inflammatory Response after Pathophysiological Cardiac Stress and Potential New Therapeutic Targets in Cardiac Disease.

Authors:  Maren Heimerl; Thomas Gausepohl; Julia H Mueller; Melanie Ricke-Hoch
Journal:  Biology (Basel)       Date:  2022-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.